Back to mobile site

Raymond James Upgrades Intercept Pharmaceuticals (ICPT) to Strong Buy; Back Up the Truck Ahead of REGENERATE Data

February 4, 2019 5:50 AM EST Send to a Friend
(Updated - February 4, 2019 8:35 AM EST)(updated to add analyst comments)Raymond James analyst Steven Seedhouse upgraded Intercept Pharmaceuticals (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login